Paul Rivard serves as Executive at MyMD Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Paul Rivard has executed 4 insider transactions totaling $300.3K, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 24, 2023 involved purchasing 150,000 shares valued at $166.5K.
Paul Rivard currently holds 400,000 shares of MyMD Pharmaceuticals, Inc. (MYMD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Paul Rivard has been a net buyer of MYMD stock. They have purchased $300.3K and sold $0 worth of shares.
Paul Rivard's most recent insider trade was on Aug 24, 2023, when they purchased 150,000 shares at $1.11 per share.
Get notified when new Form 4 filings are submitted
| $1.12 |
| Discretionary |
| Dec 8, 2022 | MYMD | $15.3K | Purchase | 10,000 | $1.53 | Discretionary |
| Nov 23, 2021 | MYMD | $90.5K | Purchase | 15,000 | $6.03 | Discretionary |